Enrolled patients will be at high risk for recurrent heart-failure hospitalizations by virtue of having elevated N-terminal pro-B-type natriuretic peptide/BNP ( > 1,200 pg/ml , or > 1,600 pg/ml if atrial fibrillation is present ) and/or recent heart failure hospitalization .